In:
Current Oncology, MDPI AG, Vol. 28, No. 3 ( 2021-04-21), p. 1558-1570
Abstract:
Colorectal cancer (CRC) is the third most commonly diagnosed cancer and second leading cause of cancer death in Canada. Organized screening programs targeting Canadians aged 50 to 74 at average risk of developing the disease have contributed to decreased rates of CRC, improved patient outcomes and reduced healthcare costs. However, data shows that recent incidence reductions are unique to the screening-age population, while rates in people under-50 are on the rise. Similar incidence patterns in the United States prompted the American Cancer Society and U.S. Preventive Services Task Force to recommend screening begin at age 45 rather than 50. We conducted a review of screening practices in Canada, framing them in the context of similar global health systems as well as the evidence supporting the recent U.S. recommendations. Epidemiologic changes in Canada suggest earlier screening initiation in average-risk individuals may be reasonable, but the balance of costs to benefits remains unclear.
Type of Medium:
Online Resource
ISSN:
1718-7729
DOI:
10.3390/curroncol28030147
Language:
English
Publisher:
MDPI AG
Publication Date:
2021
detail.hit.zdb_id:
2270777-3
Permalink